Financial Analysis: Boston Scientific Corporation (BSX) versus Mindray Medical International (MR)
Boston Scientific Corporation (NYSE: BSX) and Mindray Medical International (NYSE:MR) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, risk, earnings, dividends, institutional ownership, valuation and profitability.
Valuation and Earnings
This table compares Boston Scientific Corporation and Mindray Medical International’s revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||EBITDA||Earnings Per Share||Price/Earnings Ratio|
|Boston Scientific Corporation||$8.71 billion||4.69||$2.31 billion||$0.58||51.38|
|Mindray Medical International||N/A||N/A||N/A||N/A||N/A|
Boston Scientific Corporation has higher revenue and earnings than Mindray Medical International.
This table compares Boston Scientific Corporation and Mindray Medical International’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Boston Scientific Corporation||9.04%||23.62%||9.01%|
|Mindray Medical International||15.93%||12.70%||8.37%|
Insider and Institutional Ownership
90.5% of Boston Scientific Corporation shares are held by institutional investors. 0.7% of Boston Scientific Corporation shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
This is a summary of recent recommendations for Boston Scientific Corporation and Mindray Medical International, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Boston Scientific Corporation||0||4||13||0||2.76|
|Mindray Medical International||0||0||0||0||N/A|
Boston Scientific Corporation presently has a consensus target price of $30.96, suggesting a potential upside of 3.91%. Given Boston Scientific Corporation’s higher possible upside, equities analysts clearly believe Boston Scientific Corporation is more favorable than Mindray Medical International.
Boston Scientific Corporation beats Mindray Medical International on 7 of the 8 factors compared between the two stocks.
Boston Scientific Corporation Company Profile
Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company offers its products by seven businesses: Interventional Cardiology, Cardiac Rhythm Management, Endoscopy, Peripheral Interventions, Urology and Pelvic Health, Neuromodulation, and Electrophysiology. It operates in three segments: Cardiovascular, Rhythm Management and MedSurg. Its Cardiovascular segment consists of Interventional Cardiology and Peripheral Interventions businesses. Rhythm Management consists of Cardiac Rhythm Management and Electrophysiology businesses. MedSurg consists of Endoscopy, Urology and Pelvic Health, and Neuromodulation businesses. Its Interventional Cardiology product offerings include balloon catheters, rotational atherectomy systems, guide wires, guide catheters and embolic protection devices and diagnostic catheters used in percutaneous transluminal coronary angioplasty (PTCA) procedures.
Mindray Medical International Company Profile
Mindray Medical International Limited is a developer, manufacturer and marketer of medical devices across the world. The Company operates in three segments: patient monitoring and life support products, in-vitro diagnostic products and medical imaging systems. Its patient monitoring devices track the physiological parameters of patients, such as heart rate, blood pressure, respiration and temperature. It offers patient monitoring devices that are suitable for adult, pediatric and neonatal patients and are used principally in hospital intensive care units, operating rooms and emergency rooms. Its life support products provide operation room or intensive care unit solutions for the end users in the operating room. Its in-vitro diagnostic products provide data and analysis on blood, urine and other bodily fluid samples for clinical diagnosis and treatment. Its medical imaging systems segment includes ultrasound systems, digital radiography systems and a magnetic resonance imaging system.
Receive News & Ratings for Boston Scientific Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Boston Scientific Corporation and related companies with MarketBeat.com's FREE daily email newsletter.